Inmune Bio (INMB) Enterprise Value (2019 - 2026)
Inmune Bio (INMB) recorded Enterprise Value of $26.66 million in Q2 2026, down 4.9% from $28.04 million a year earlier but up 207.1% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Enterprise Value (2019 - 2026) Analysis & Trends
On a TTM basis, Inmune Bio's Enterprise Value came in at -$47.18 million as of Jun 30, 2026; for FY2025, it came in at $16.72 million, down 79.9% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of -39.7% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $83.13 million in FY2024 (-50.0%), $166.28 million in FY2023 (+169.8%), $61.62 million in FY2022 (-42.5%) and $107.19 million in FY2021 (-49.0%).
- Quarterly Enterprise Value has ranged from $8.68 million in Q1 2026 to $262.05 million in Q3 2021 over the past five years.
- On a year-over-year basis, Enterprise Value has declined for seven consecutive quarters, with an average decline of 48.0% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 184.8% in Q1 2024, against a decline of 94.6% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $8.68 million (Q1 2026), $16.72 million (Q4 2025) and $27.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Inmune Bio | 55.31 Mn | -36.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.66 Mn |
| Mar 31, 2026 | 8.68 Mn |
| Dec 31, 2025 | 16.72 Mn |
| Sep 30, 2025 | 27.30 Mn |
| Jun 30, 2025 | 28.04 Mn |
| Mar 31, 2025 | 159.75 Mn |
| Dec 31, 2024 | 83.13 Mn |
| Sep 30, 2024 | 85.96 Mn |
| Jun 30, 2024 | 142.74 Mn |
| Mar 31, 2024 | 184.92 Mn |
| Dec 31, 2023 | 166.28 Mn |
| Sep 30, 2023 | 79.68 Mn |
| Jun 30, 2023 | 115.12 Mn |
| Mar 31, 2023 | 64.93 Mn |
| Dec 31, 2022 | 61.62 Mn |
| Sep 30, 2022 | 53.86 Mn |
| Jun 30, 2022 | 97.43 Mn |
| Mar 31, 2022 | 84.38 Mn |
| Dec 31, 2021 | 107.19 Mn |
| Sep 30, 2021 | 262.05 Mn |
API Access
Inmune Bio Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();